Table 3 The stage of CAM and funisitis in LD, SPTB, and control groups
Variable | Participants | P-valuea | ||
|---|---|---|---|---|
LD | SPTB | Control | ||
n = 83 | n = 144 | n = 90 | ||
CAM, % | 63.9 | 52.1 | 14.4 | < 0.01 |
CAM stage, % | ||||
 Not presence | 36.1 | 47.9 | 85.6 | < 0.01 |
 1 | 9.6 | 14.6 | 6.7 | |
 2 | 24.1 | 13.2 | 1.1 | |
 3 | 30.1 | 24.3 | 6.7 | |
CAM stage ≥2, % | 54.2 | 37.5 | 7.8 | < 0.01 |
Funisitis, % | 39.2 | 24.8 | 3.4 | < 0.01 |
Funisitis stage, % | ||||
 Not presence | 61.7 | 75.2 | 97.7 | < 0.01 |
 1 | 4.9 | 3.5 | 0.0 | |
 2 | 32.1 | 18.4 | 2.3 | |
 3 | 1.2 | 2.8 | 0.0 | |
Funisitis stage ≥2, % | 32.1 | 21.3 | 2.3 | < 0.01 |